Myraqa Acquired By Illumina
Redwood City-based Myraqa, which provides regulatory and quality consulting services for the molecular diagnostics market, has been acquired by Illumina. Financial terms of the deal were not disclosed. Myraqa provides regulatory strategy and application support to biopharmaceuticals firms, including PMAs, pre-submissions, IDEs, 510(k)s, and other related areas. Illumina is based in San Diego, California.
posted on Wednesday, July 16, 2014
Related companies:
Myraqa
Related stories:
> NextBio Acquired By Illumina
> Illumina Ventures Gets $230M For First Venture Capital Fund
> GenoLogics Acquired By Illumina
> Grail Nears $1 Billion In Series B
> Genome Medical Gains $23M
silicontap.com Home